While electronic cigarettes have won over users worldwide, they remain a point of contention. Despite the many scientific stufies proving its benefits, those who oppose vaping are quite vocal. Stanton Glantz, a prominent anti-vaping researcher, believes that the habit can double the risk of heart failure.
He bases this statement on a study that is currently under review. Glantz presented the results during the anual conference for the Society for Research on Nicotine and Tobacco. Based on a database obtained from the National Health Interview Survey from 2014 to 2016, the study focused on health issues in America. The research pointed to a connection between smoking and/or vaping habits and heart failure in the studied population.
According to the study, there is evidence of a link between daily vaping and heart failure among survey participants. This was enough for Glantz to conclude a direct causal link, stating that vaping increased the risk of heart failure. Still under review, this study has been criticized and discussed widely, in particular in the scientific community.
Remember that vaping enthusiasts are often former-smokers
This is the main criticism voiced by Michael Siegel, from Boston University. Siegel deplored the lack of long-term data. In his opinion, participants in the survey most likely turned to vaping after a heart failure incident. The very opposite of Glantz’s conclusions.
The study was also heavily criticized by Carl V. Philips, who stated it was regretful there was no chronological data on when heart failure occurred and when vaping was taken up. This information is vital to establish a causal link. He added that the data used did not exclude the possibility that it was smoking that led to cardio-vascular issues.
It is important to remember that many studies have already established very low levels of toxicity in e-cigarettes, be it for the heart, the lungs, or the respiratory system. Electronic cigarettes remain the most widely used alternative for smokers trying to quit, reducing health risks by 95%.